Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Kasse

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Therapeutics|January 23, 2023
Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer ExcipientJohn H Klich, Catherine M Kasse, Joseph L Mann, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depotCatherine M Kasse, Anthony C Yu, Abigail E Powell, et al.
Biomaterials Science|February 1, 2023
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depotCatherine M Kasse, Anthony C Yu, Abigail E Powell, et al.
Cell Reports. Medicine|November 22, 2023
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes managementAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of DiabetesAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 2, 2025
Hydrogel formulations for sustained-release of broadly neutralizing antibodiesCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Engineering Sustained-Release Broadly Neutralizing Antibody FormulationsCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Therapeutics|January 23, 2023
Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer ExcipientJohn H Klich, Catherine M Kasse, Joseph L Mann, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depotCatherine M Kasse, Anthony C Yu, Abigail E Powell, et al.
Biomaterials Science|February 1, 2023
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depotCatherine M Kasse, Anthony C Yu, Abigail E Powell, et al.
Cell Reports. Medicine|November 22, 2023
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes managementAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of DiabetesAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 2, 2025
Hydrogel formulations for sustained-release of broadly neutralizing antibodiesCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Engineering Sustained-Release Broadly Neutralizing Antibody FormulationsCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Pageof 1